Tofy Mussivand

From Wikipedia, the free encyclopedia
  (Redirected from Toffy Musivand)
Jump to: navigation, search
Tofigh Mussivand
Born Varkaneh, Hamadan Province, Iran
Nationality Iranian-Canadian
Occupation Engineer
Known for Artificial Cardiac Pump

Tofigh Mussivand (Lurish: Tufi Mussivend, Persian:توفیق موسیوند), born c. 1943 in Varkaneh, Hamadan Province, Iran) is an Iranian-Canadian[1] medical engineer who invented an Artificial Cardiac Pump, a device that pumps blood and takes over the function of breathing during a heart surgery.[2][unreliable source?] [3]

He is currently Professor of Surgery and Engineering at the University of Ottawa and Carleton University; Chair and Director, Cardiovascular Devices Division of the University of Ottawa Heart Institute (UOHI); and Medical Devices Program of both the University of Ottawa and Carleton University. He is an honorary member of the Iranian Academy of Medical Sciences.

Mussivand was born to Lurish Iranian parents in the village of Varkaneh in Hamedan. Before leaving Varkaneh to study at Tehran, he was a goat herder. He studied engineering at Tehran University and University of Alberta.[1] He has worked for the Canadian government, crown corporations, and the private sector. Mussivand went on to receive his doctorate in Medical Engineering and Medical Sciences at the University of Akron and Northeastern Ohio Universities College of Medicine. Thereafter, Mussivand joined the Cleveland Clinic Hospital and Research Foundation. In 1989, Mussivand returned to Canada.

The Artificial Cardiac Pump temporarily takes over the function of breathing and pumping blood for a patient. It has two parts, the pump and the aerator. Cardiac pumps are most often used in heart surgery, so that a patient's heart can be disconnected from the body for longer than the twenty minutes or so it takes for a prepared patient to die.

Selected publications[edit]

  • Mussivand, Tofy (2004). "856-1 Mechanical circulatory support: Evolving trends in support duration". Journal of the American College of Cardiology. Elsevier Biomedical. 43 (5): A233. doi:10.1016/s0735-1097(04)90994-1. ISSN 0735-1097. OCLC 98570923. 
  • Imachi, Kou; Mussivand, Tofy (2010). "Outline of the International Organization for Standardization Standard for Circulatory Support Devices (ISO 14708-5)". Artificial Organs. Blackwell Publishing. 34 (9): 695–698. doi:10.1111/j.1525-1594.2010.01097.x. ISSN 1525-1594. OCLC 666863666. 
  • Mussivand, Tofy (2003). "Honoring Living Legends". Artificial Organs. Blackwell Science. 27 (6): 581–582. doi:10.1046/j.1525-1594.2003.07217.x. ISSN 1525-1594. OCLC 437591192. 
  • Mielniczuk, Lisa; Mussivand, Tofy; Davies, Ross; Mesana, Thierry G (2004). "Patient Selection for Left Ventricular Assist Devices". Artificial Organs. Blackwell Publishing. 28 (2): 152–157. doi:10.1111/j.1525-1594.2003.47333.x. ISSN 1525-1594. OCLC 437941681. 
  • Mussivand, Tofy (1998). "Lessons Learned from the Grandfather of Artificial Organs". Artificial Organs. New York, Raven Press. 22.11: 985. ISSN 1525-1594. OCLC 92216345. 
  • Mussivand, Tofy (1999). "ORIGINAL ARTICLES - Mechanical Circulatory Devices for the Treatment of Heart Failure - The results of a prospective trial of partial left ventriculectomy (PLV) in patients with idiopathic dilated cardiomyopathy, left ventricular end-diastolic diameter (LVEDD) > 7 cm, refractory NYHA Class IV symptoms, and depressed exercise oxygen consumption studies are reported. PLV can be performed with acceptable early and 12-month mortality. Significant improvement in LVEF, LVEDD, and NYHA Class are seen at up to 12-month follow-up". Journal of cardiac surgery. Futura. 14 (3): 218. ISSN 0886-0440. OCLC 96424197.